IMMUNITYBIO, INC. Other Current Assets
IMMUNITYBIO, INC. (IBRX) had Other Current Assets of $3.02 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-05-07
- 2026-03-31: Other Assets, Current $3.02M.
- 2025-12-31: Other Assets, Current $2.13M.
- 2025-09-30: Other Assets, Current $2.51M.
- 2025-06-30: Other Assets, Current $1.64M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $3.02M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.13M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $2.51M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.64M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $2.35M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.30M 10-K · filed 2026-02-23 | $1.12M 10-K · filed 2025-03-03 |
| 2024-09-30 | $1.37M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $480.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $2.58M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.54M 10-K · filed 2025-03-03 | $2.65M 10-K · filed 2024-03-19 |
| 2023-09-30 | $4.38M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.55M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $4.43M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.98M 10-K · filed 2024-03-19 | $3.73M 10-K · filed 2023-03-01 |
| 2022-09-30 | $3.24M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $3.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $3.98M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.96M 10-K · filed 2023-03-01 | $5.55M 10-Q · filed 2022-05-10 |
| 2021-09-30 | $255.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $283.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $338.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $110.00K 10-Q · filed 2021-11-12 | $44.00K 10-K · filed 2021-03-04 |
| 2020-09-30 | $90.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $67.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $78.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $677.00K 8-K/A · filed 2021-04-22 | $24.00K 10-K · filed 2020-03-25 |
| 2019-09-30 | $48.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $51.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $80.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $42.00K 10-K · filed 2020-03-25 | |
| 2018-09-30 | $203.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $263.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $328.00K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $275.00K 10-K · filed 2019-03-13 | $398.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $286.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $302.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $242.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $275.00K 10-K · filed 2018-03-12 | $180.00K 10-K · filed 2017-03-15 |
| 2016-09-30 | $252.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $11.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $190.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |